InhaleRx Breathes Easy with $38.5M Funding Boost for Clinical Development Goals
InhalerX Secures $38,500,000 Funding to Fully Fund Clinical Development Plans InhalerX, a leading pharmaceutical company specializing in the development of innovative inhalation technologies,